OPTIMIZERX CORP (OPRX)
US68401U2042 - Common Stock
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come in ahead...
Commit To Buy OptimizeRx Corp At $5, Earn 6.8% Annualized Using Options
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Let's have a look at the gap up and gap down stocks in today's session.
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
Q4 revenue of $28.4 million, increasing 44% year-over-yearQ4 gross profit increased 43% year-over-year to $17.8 million with gross margins coming in at 63%...
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
Market Embraces Disruptive AI-Powered Capabilities
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
Market Embraces Disruptive AI-Powered Capabilities...
OptimizeRx Enters Oversold Territory (OPRX)
7 Top Undervalued Stocks Primed for a Multibagger Recovery
These seven undervalued stocks are trading at discounted prices but have the potential to deliver multibagger returns in the coming years.
OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023
OPRX stock results show that OptimizeRx beat on revenue for the fourth quarter of 2023.
OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OptimizeRx (NASDAQ:OPRX) just reported results for the fourth quarter of 2023.T...
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...
Oversold Conditions For OptimizeRx (OPRX)
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
Empowering healthcare providers to remove barriers to care
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
Empowering healthcare providers to remove barriers to care...
OptimizeRx to Participate in Upcoming Investor Conferences
OptimizeRx to Participate in Upcoming Investor Conferences
WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...
Commit To Purchase OptimizeRx At $12.50, Earn 16.4% Annualized Using Options
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
WALTHAM, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
WALTHAM, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
WALTHAM, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...
Notable Monday Option Activity: IDT, OPRX, WYNN
Notable Monday Option Activity: OPRX, ADI, GES
Commit To Buy OptimizeRx At $7.50, Earn 15.3% Using Options
Notable Monday Option Activity: SPHR, SNOW, OPRX